
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin
Patrick L. Apopa, Lisa Alley, Rosalind B. Penney, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 89
Patrick L. Apopa, Lisa Alley, Rosalind B. Penney, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 89
Showing 1-25 of 89 citing articles:
The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy
Ariel Ramírez-Labrada, Dolores Isla, Á. Artal, et al.
Trends in cancer (2020) Vol. 6, Iss. 2, pp. 86-97
Open Access | Times Cited: 167
Ariel Ramírez-Labrada, Dolores Isla, Á. Artal, et al.
Trends in cancer (2020) Vol. 6, Iss. 2, pp. 86-97
Open Access | Times Cited: 167
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Ruomeng Li, Jing Li, Xikun Zhou
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Intratumoural microbiota: a new frontier in cancer development and therapy
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 69
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 69
The characterization of lung microbiome in lung cancer patients with different clinicopathology.
Danhui Huang, Xiao-Fang Su, Man Yuan, et al.
PubMed (2019) Vol. 9, Iss. 9, pp. 2047-2063
Closed Access | Times Cited: 94
Danhui Huang, Xiao-Fang Su, Man Yuan, et al.
PubMed (2019) Vol. 9, Iss. 9, pp. 2047-2063
Closed Access | Times Cited: 94
Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes
Elisabeth Taucher, Iurii Mykoliuk, Joerg Lindenmann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Elisabeth Taucher, Iurii Mykoliuk, Joerg Lindenmann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Microbiota and lung cancer
Taichiro Goto
Seminars in Cancer Biology (2022) Vol. 86, pp. 1-10
Open Access | Times Cited: 49
Taichiro Goto
Seminars in Cancer Biology (2022) Vol. 86, pp. 1-10
Open Access | Times Cited: 49
Tumor microbiome – an integral part of the tumor microenvironment
Sona Ciernikova, Aneta Sevcikova, Viola Stevurkova, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 40
Sona Ciernikova, Aneta Sevcikova, Viola Stevurkova, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 40
Sex Differences in Lung Cancer
Lauren May, Kathryn H. Shows, Patrick Nana‐Sinkam, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3111-3111
Open Access | Times Cited: 36
Lauren May, Kathryn H. Shows, Patrick Nana‐Sinkam, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3111-3111
Open Access | Times Cited: 36
Streptococcus pneumoniae promotes lung cancer development and progression
Ning Li, Huifen Zhou, Van K. Holden, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105923-105923
Open Access | Times Cited: 28
Ning Li, Huifen Zhou, Van K. Holden, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105923-105923
Open Access | Times Cited: 28
Human Lung Microbiome on the Way to Cancer
О. В. Ковалева, Daniil Romashin, I. B. Zborovskaya, et al.
Journal of Immunology Research (2019) Vol. 2019, pp. 1-6
Open Access | Times Cited: 68
О. В. Ковалева, Daniil Romashin, I. B. Zborovskaya, et al.
Journal of Immunology Research (2019) Vol. 2019, pp. 1-6
Open Access | Times Cited: 68
Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
Keshav Raj Paudel, Vivek Dharwal, Vyoma K. Patel, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 59
Keshav Raj Paudel, Vivek Dharwal, Vyoma K. Patel, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 59
Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms
Nana Xu, Lei Wang, Chenxi Li, et al.
Translational Lung Cancer Research (2020) Vol. 9, Iss. 4, pp. 1554-1568
Open Access | Times Cited: 55
Nana Xu, Lei Wang, Chenxi Li, et al.
Translational Lung Cancer Research (2020) Vol. 9, Iss. 4, pp. 1554-1568
Open Access | Times Cited: 55
Toxic compounds produced by cyanobacteria belonging to several species of the order Nostocales: A review
Bahareh Nowruzi, Samaneh Jafari Porzani
Journal of Applied Toxicology (2020) Vol. 41, Iss. 4, pp. 510-548
Closed Access | Times Cited: 52
Bahareh Nowruzi, Samaneh Jafari Porzani
Journal of Applied Toxicology (2020) Vol. 41, Iss. 4, pp. 510-548
Closed Access | Times Cited: 52
Airway Microbiota as a Modulator of Lung Cancer
Taichiro Goto
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3044-3044
Open Access | Times Cited: 51
Taichiro Goto
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3044-3044
Open Access | Times Cited: 51
Microbiota Biomarkers for Lung Cancer
Qixin Leng, Van K. Holden, Janaki Deepak, et al.
Diagnostics (2021) Vol. 11, Iss. 3, pp. 407-407
Open Access | Times Cited: 51
Qixin Leng, Van K. Holden, Janaki Deepak, et al.
Diagnostics (2021) Vol. 11, Iss. 3, pp. 407-407
Open Access | Times Cited: 51
Relationship of the lung microbiome with PD-L1 expression and immunotherapy response in lung cancer
Hye Jin Jang, Ji Yeon Choi, Kangjoon Kim, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Hye Jin Jang, Ji Yeon Choi, Kangjoon Kim, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy
Faizan Haider Khan, Basharat Bhat, Bashir Ahmad Sheikh, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 732-742
Closed Access | Times Cited: 41
Faizan Haider Khan, Basharat Bhat, Bashir Ahmad Sheikh, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 732-742
Closed Access | Times Cited: 41
Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment
Federica Pizzo, Zaira Maroccia, Ivano Hammarberg Ferri, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6138-6138
Open Access | Times Cited: 32
Federica Pizzo, Zaira Maroccia, Ivano Hammarberg Ferri, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6138-6138
Open Access | Times Cited: 32
The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment
Anna McLean, Steven Kao, David Barnes, et al.
Lung Cancer (2022) Vol. 165, pp. 124-132
Closed Access | Times Cited: 29
Anna McLean, Steven Kao, David Barnes, et al.
Lung Cancer (2022) Vol. 165, pp. 124-132
Closed Access | Times Cited: 29
Health risk assessment of lake water contaminated with microcystins for fruit crop irrigation and farm animal drinking
El Mahdi Redouane, Zakaria Tazart, Majida Lahrouni, et al.
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 33, pp. 80234-80244
Open Access | Times Cited: 22
El Mahdi Redouane, Zakaria Tazart, Majida Lahrouni, et al.
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 33, pp. 80234-80244
Open Access | Times Cited: 22
Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected
Jiuling Cheng, Lujia Zhou, Huaqi Wang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 7
Jiuling Cheng, Lujia Zhou, Huaqi Wang
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 7
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis
Sumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Archivos de Bronconeumología (2024) Vol. 60, pp. S46-S58
Closed Access | Times Cited: 7
Sumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Archivos de Bronconeumología (2024) Vol. 60, pp. S46-S58
Closed Access | Times Cited: 7
Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
Rajan Thapa, A Magar, Jesus Shrestha, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 7
Rajan Thapa, A Magar, Jesus Shrestha, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 7
Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing
Junpeng Wang, Xin Li, Xiaoqiang Wu, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 147, Iss. 2, pp. 481-491
Closed Access | Times Cited: 42
Junpeng Wang, Xin Li, Xiaoqiang Wu, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 147, Iss. 2, pp. 481-491
Closed Access | Times Cited: 42
The microbiome(s) and cancer: know thy neighbor(s)
Paloma González‐Sánchez, Gina M. DeNicola
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 332-343
Open Access | Times Cited: 40
Paloma González‐Sánchez, Gina M. DeNicola
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 332-343
Open Access | Times Cited: 40